ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 102 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2016. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $419,000 | -69.7% | 9,047 | -76.9% | 0.01% | -68.4% |
Q1 2017 | $1,384,000 | +235.1% | 39,196 | -6.2% | 0.04% | +322.2% |
Q2 2016 | $413,000 | +80.3% | 41,780 | +305.8% | 0.01% | +125.0% |
Q4 2015 | $229,000 | -61.4% | 10,296 | -59.1% | 0.00% | -60.0% |
Q3 2015 | $594,000 | – | 25,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |